Table 4.
Author | Approach | Subjects | Longitudinal Strain | Circumferential Strain | Radial strain |
---|---|---|---|---|---|
Yingchoncharoen et al.39 | Meta-analysis of 24 studies using various ultrasound systems and speckle-tracking software | 2597 subjects from 24 studies | −19.7 ± 0.4% | −23.3 ± 0.7% | 47.3 ± 1.9% |
Manovel et al.112 | Vivid 7 with EchoPAC (GE Healthcare, Horten, Norway), speckle-tracking | 28 healthy subjects (age 38 ± 12) | −21.95 ± 1.8% | −23.18 ± 3.3% | 46.97 ± 5.5% |
Manovel et al.112 | Artida 4D and 2D Wall Motion tracking (Toshiba Medical Systems), speckle tracking | 28 healthy subjects (age 38 ± 12) | −22.28 ± 2.1% | −27.17 ± 4.7% | 40.74 ± 4.3% |
Marwick et al.18 | Vivid 7 with EchoPAC (GE Healthcare, Horten, Norway), speckle-tracking | 242 healthy subjects | −18.6 ±1.6% | ||
Dalen et al.31 | Vivid 7 (GE Healthcare), combination of TDI and speckle tracking | 1266 free from DM or CV disease | −17.4 ± 2.3% (females) −15.9% ± 2.3% (males) |
||
Dalen et al. 31 | Vivid 7 with Automated Function Imaging (GE Healthcare), combination of TDI and speckle tracking | 57 subjects free from cardiovascular disease | −17.4 ± 3.4% | ||
Dalen et al. 31 | Vivid 7 (GE Healthcare), TDI with fixed Region of Interest | 57 subjects free from cardiovascular disease | −17.7 ± 8.5% | ||
Dalen et al. 31 | Vivid 7 and Automated Function Imaging (GE Healthcare), speckle-tracking | 57 subjects free from cardiovascular disease | −18.4 ± 5.9% | ||
Sun et al.120 | Vivid 7 (GE Healthcare), Speckle-tracking | 228 healthy subjects | −20.4 ± 3.4% | −22.9 ± 3.1% | 42.6±12.9% |
Kuznetsova et al.121 | Vivid 7 and EchoPAC (GE Healthcare), TDI strain | 480 subjects from a general population | −22.9 ± 1.9% | 59.2 ± 2.5% |